Global HIV Drugs Market Research Report 2023

Report ID: 1989034 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 HIV Drugs Market Overview
    1.1 Product Overview and Scope of HIV Drugs
    1.2 HIV Drugs Segment by Type
        1.2.1 Global HIV Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Multi-Class Combination Products
        1.2.3 Nucleoside Reverse Transcriptase Inhibitors
        1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
        1.2.5 Protease Inhibitors
        1.2.6 Fusion Inhibitors
        1.2.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
        1.2.8 HIV Integrase Strand Transfer Inhibitors
    1.3 HIV Drugs Segment by Application
        1.3.1 Global HIV Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Others
    1.4 Global HIV Drugs Market Size Estimates and Forecasts
        1.4.1 Global HIV Drugs Revenue 2017-2028
        1.4.2 Global HIV Drugs Sales 2017-2028
        1.4.3 HIV Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 HIV Drugs Market Competition by Manufacturers
    2.1 Global HIV Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global HIV Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global HIV Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers HIV Drugs Manufacturing Sites, Area Served, Product Type
    2.5 HIV Drugs Market Competitive Situation and Trends
        2.5.1 HIV Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest HIV Drugs Players Market Share by Revenue
        2.5.3 Global HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Drugs Retrospective Market Scenario by Region
    3.1 Global HIV Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global HIV Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America HIV Drugs Market Facts & Figures by Country
        3.3.1 North America HIV Drugs Sales by Country
        3.3.2 North America HIV Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe HIV Drugs Market Facts & Figures by Country
        3.4.1 Europe HIV Drugs Sales by Country
        3.4.2 Europe HIV Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific HIV Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific HIV Drugs Sales by Region
        3.5.2 Asia Pacific HIV Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America HIV Drugs Market Facts & Figures by Country
        3.6.1 Latin America HIV Drugs Sales by Country
        3.6.2 Latin America HIV Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa HIV Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa HIV Drugs Sales by Country
        3.7.2 Middle East and Africa HIV Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global HIV Drugs Historic Market Analysis by Type
    4.1 Global HIV Drugs Sales Market Share by Type (2017-2022)
    4.2 Global HIV Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global HIV Drugs Price by Type (2017-2022)
5 Global HIV Drugs Historic Market Analysis by Application
    5.1 Global HIV Drugs Sales Market Share by Application (2017-2022)
    5.2 Global HIV Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global HIV Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Bristol-Myers Squibb
        6.1.1 Bristol-Myers Squibb Corporation Information
        6.1.2 Bristol-Myers Squibb Description and Business Overview
        6.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Bristol-Myers Squibb HIV Drugs Product Portfolio
        6.1.5 Bristol-Myers Squibb Recent Developments/Updates
    6.2 Gilead Sciences
        6.2.1 Gilead Sciences Corporation Information
        6.2.2 Gilead Sciences Description and Business Overview
        6.2.3 Gilead Sciences HIV Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Gilead Sciences HIV Drugs Product Portfolio
        6.2.5 Gilead Sciences Recent Developments/Updates
    6.3 GlaxoSmithKline
        6.3.1 GlaxoSmithKline Corporation Information
        6.3.2 GlaxoSmithKline Description and Business Overview
        6.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GlaxoSmithKline HIV Drugs Product Portfolio
        6.3.5 GlaxoSmithKline Recent Developments/Updates
    6.4 Johnson & Johnson
        6.4.1 Johnson & Johnson Corporation Information
        6.4.2 Johnson & Johnson Description and Business Overview
        6.4.3 Johnson & Johnson HIV Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Johnson & Johnson HIV Drugs Product Portfolio
        6.4.5 Johnson & Johnson Recent Developments/Updates
    6.5 Merck
        6.5.1 Merck Corporation Information
        6.5.2 Merck Description and Business Overview
        6.5.3 Merck HIV Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Merck HIV Drugs Product Portfolio
        6.5.5 Merck Recent Developments/Updates
7 HIV Drugs Manufacturing Cost Analysis
    7.1 HIV Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of HIV Drugs
    7.4 HIV Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 HIV Drugs Distributors List
    8.3 HIV Drugs Customers
9 HIV Drugs Market Dynamics
    9.1 HIV Drugs Industry Trends
    9.2 HIV Drugs Market Drivers
    9.3 HIV Drugs Market Challenges
    9.4 HIV Drugs Market Restraints
10 Global Market Forecast
    10.1 HIV Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of HIV Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of HIV Drugs by Type (2023-2028)
    10.2 HIV Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of HIV Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of HIV Drugs by Application (2023-2028)
    10.3 HIV Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of HIV Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of HIV Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global HIV Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global HIV Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global HIV Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global HIV Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global HIV Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global HIV Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global HIV Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global HIV Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market HIV Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers HIV Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers HIV Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global HIV Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global HIV Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global HIV Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global HIV Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global HIV Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America HIV Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America HIV Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America HIV Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe HIV Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe HIV Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe HIV Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific HIV Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific HIV Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific HIV Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific HIV Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America HIV Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America HIV Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America HIV Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa HIV Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa HIV Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa HIV Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global HIV Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global HIV Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global HIV Drugs Revenue Share by Type (2017-2022)
    Table 43. Global HIV Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global HIV Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global HIV Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global HIV Drugs Revenue Share by Application (2017-2022)
    Table 48. Global HIV Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Bristol-Myers Squibb Corporation Information
    Table 50. Bristol-Myers Squibb Description and Business Overview
    Table 51. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Bristol-Myers Squibb HIV Drugs Product
    Table 53. Bristol-Myers Squibb Recent Developments/Updates
    Table 54. Gilead Sciences Corporation Information
    Table 55. Gilead Sciences Description and Business Overview
    Table 56. Gilead Sciences HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Gilead Sciences HIV Drugs Product
    Table 58. Gilead Sciences Recent Developments/Updates
    Table 59. GlaxoSmithKline Corporation Information
    Table 60. GlaxoSmithKline Description and Business Overview
    Table 61. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. GlaxoSmithKline HIV Drugs Product
    Table 63. GlaxoSmithKline Recent Developments/Updates
    Table 64. Johnson & Johnson Corporation Information
    Table 65. Johnson & Johnson Description and Business Overview
    Table 66. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Johnson & Johnson HIV Drugs Product
    Table 68. Johnson & Johnson Recent Developments/Updates
    Table 69. Merck Corporation Information
    Table 70. Merck Description and Business Overview
    Table 71. Merck HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Merck HIV Drugs Product
    Table 73. Merck Recent Developments/Updates
    Table 74. Production Base and Market Concentration Rate of Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. HIV Drugs Distributors List
    Table 77. HIV Drugs Customers List
    Table 78. HIV Drugs Market Trends
    Table 79. HIV Drugs Market Drivers
    Table 80. HIV Drugs Market Challenges
    Table 81. HIV Drugs Market Restraints
    Table 82. Global HIV Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 83. Global HIV Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 84. Global HIV Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 85. Global HIV Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 86. Global HIV Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 87. Global HIV Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 88. Global HIV Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 89. Global HIV Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 90. Global HIV Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 91. Global HIV Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 92. Global HIV Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 93. Global HIV Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of HIV Drugs
    Figure 2. Global HIV Drugs Market Share by Type in 2021 & 2028
    Figure 3. Multi-Class Combination Products Product Picture
    Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
    Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
    Figure 6. Protease Inhibitors Product Picture
    Figure 7. Fusion Inhibitors Product Picture
    Figure 8. Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
    Figure 9. HIV Integrase Strand Transfer Inhibitors Product Picture
    Figure 10. Global HIV Drugs Market Share by Application in 2021 & 2028
    Figure 11. Hospital Pharmacies
    Figure 12. Retail Pharmacies
    Figure 13. Online Pharmacies
    Figure 14. Others
    Figure 15. Global HIV Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global HIV Drugs Market Size (2017-2028) & (US$ Million)
    Figure 17. Global HIV Drugs Sales (2017-2028) & (K Units)
    Figure 18. HIV Drugs Sales Share by Manufacturers in 2021
    Figure 19. Global HIV Drugs Revenue Share by Manufacturers in 2021
    Figure 20. The Global 5 and 10 Largest HIV Drugs Players: Market Share by Revenue in 2021
    Figure 21. HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global HIV Drugs Sales Market Share by Region (2017-2022)
    Figure 23. Global HIV Drugs Sales Market Share by Region in 2021
    Figure 24. Global HIV Drugs Revenue Market Share by Region (2017-2022)
    Figure 25. Global HIV Drugs Revenue Market Share by Region in 2021
    Figure 26. U.S. HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Canada HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Germany HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. France HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. U.K. HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Italy HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Russia HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Japan HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. South Korea HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. India HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Australia HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Taiwan HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Indonesia HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Thailand HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Malaysia HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Philippines HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Vietnam HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Mexico HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Brazil HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Argentina HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Turkey HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Saudi Arabia HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. U.A.E HIV Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Sales Market Share of HIV Drugs by Type (2017-2022)
    Figure 51. Manufacturing Cost Structure of HIV Drugs
    Figure 52. Manufacturing Process Analysis of HIV Drugs
    Figure 53. HIV Drugs Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Frequently Asked Questions
HIV Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HIV Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HIV Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

HMI Software

HMI Software market is segmented by players, region (country), by Type and by Application. Player ... Read More

Hockey Equipment

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More